Phase 4 Bone Loss Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Bone, Exercise, Alendronate, and Caloric Restriction
Bone Loss
Wake Forest University Health Sciences900 enrolled2 locationsNCT05764733
Recruiting
Phase 4
Evaluation of Erythropoietin on Alveolar Ridge Preservation
Alveolar Bone Loss
Ain Shams University15 enrolled1 locationNCT06513039
Recruiting
Phase 4
Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model
Bone LossRegenerative Inflammation
Mario Pérez Sayáns30 enrolled2 locationsNCT06338241
Recruiting
Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
Bone LossChange in Bone Mineral Density
Insud Pharma1,710 enrolled20 locationsNCT05303636
Not Yet Recruiting
Phase 4
A randomised, double-blind, one-year controlled trial comparing Aclasta (zoledronic acid) 5 mg intravenously (i/v) against placebo infusion in patients with anti-epileptic (AED) drug induced bone loss
Use of anti-epileptic drugsBone loss (osteoporosis)
Melbourne Health60 enrolled1 locationACTRN12611000507987
Completed
Phase 4
Calcium supplementation and its effect on bone loss in renal transplant recipients.
Bone loss in renal transplant recipients.Hyperparathyroidism in renal transplant recipients.
Dr Patrick T Coates35 enrolled1 locationACTRN12609000250235